ASP9853, an Inhibitor of Inducible Nitric Oxide Synthase Dimerization, in Combination With Docetaxel: Preclinical Investigation and a Phase I Study in Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-016-2967-0

Related search